Roth Capital upgraded Core Scientific (CORZ) to Buy from Neutral with a price target of $23.50, up from $17. The firm now assumes the company’s takeover by CoreWeave (CRWV) does not go through amid increasing activity and commentary around voting against the deal. CoreWeave called its bid “best and final,” and the fixed-ratio spread has inverted, the analyst tells investors in a research note. Roth upgraded Core Scientific after pivoting to a standalone model that assumes the company leases its power pipeline primarily for high performance compute.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Core Scientific Faces Legal Challenges Over Merger
- Core Scientific upgraded, HP downgraded: Wall Street’s top analyst calls
- B. Riley upgrades Core Scientific on likelihood of takeover failing
- Core Scientific upgraded to Buy from Neutral at B. Riley
- CoreWeave won’t raise bid for Core Scientific, Bloomberg reports